Skip to content
10-K

Annual Report

GFR PHARMACEUTICALS INC

0001437749-12-002718

← back to feed
Filed
Mar 23, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 22, 2012 42.08M sh
Shares Diluted FY 2011 · Dec 31, 2011 42.08M sh
Shares Diluted FY 2011 · Dec 31, 2010 42.08M sh
Capex FY 2011 · Dec 31, 2010 $770.52K
Operating Cash Flow FY 2011 · Dec 31, 2010 $2.44M
Stockholders Equity FY 2011 · Dec 31, 2010 $6.36M
Current Liabilities FY 2011 · Dec 31, 2010 $1.05M
Total Liabilities FY 2011 · Dec 31, 2010 $1.86M
Current Assets FY 2011 · Dec 31, 2010 $1.72M
Total Assets FY 2011 · Dec 31, 2010 $8.82M
Sga Expense FY 2011 · Dec 31, 2010 $801.82K
Net Income FY 2011 · Dec 31, 2010 $2.45M
Operating Income FY 2011 · Dec 31, 2010 $2.97M
Gross Profit FY 2011 · Dec 31, 2010 $3.69M
Cost Of Revenue FY 2011 · Dec 31, 2010 $674.18K
Cash And Equivalents FY 2011 · Dec 31, 2009 $55.49K